Answer
In patients with myelofibrosis, fedratinib (Inrebic) has an effective half-life of 41 hours and a terminal half-life of approximately 114 hours.
Sources for this answer
- Inrebic 100 mg hard capsulesBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 9Document updated
Sources checked